Commercialization: Page 117
-
PharmaVoice Team/PharmaVoice
Sea Change
Sea Change Turning the tide The Product Life-Cycle Management Wave Commonly thought of as a strategy for the end-phase of a drug, life-cycle management increasingly is being deployed by life-sciences executives earlier in the development phases to maximize product value, provide greater benefits ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
executive appointments and promotions in the healthcare industry Pharma POOL Robert Boisclair Dr. Richard Bowles Steve Chellevold Mary-Frances Faraji Brent Saunders Schering-Plough Announces Senior-Level Management Changes Schering-Plough, Kenilworth, N.J., has made senior-level management change...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
talent pool executive appointments and promotions in the healthcare industry Pharma POOL Robert Bertolini Schering-Plough Appoints Executive VP, Chief Financial Officer Schering-Plough has appointed Robert J. Bertolini as executive VP and chief financial officer. He also serves on the Schering-Pl...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare industry Parents Hesitant to let Children Participate in Clinical Trials Only one in four U.S. adults would consider allowing their children to participate in clinical trials. This is one of the results of a Harris Interact...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Developing a CDISC Intelligence Quotient
Developing a CDISC Intelligence Quotient Some CDISC members envision a time in the future when at least three of the CDISC standards will be combined into one. Until then, the question remains: what does CDISC-compliant mean to you? By breaking down the components of CDISC, people can better unde...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies Corbett Accel Healthcare Adds New Interactive Unit The new business unit, Kinect, fuses strategy with design and technology. Corbett Accel Healthcare Group has expanded its interactive offerings with the establishment of Kinect. ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
January 10-11 Clarifying the Regulatory Framework of Pharmaceutical Marketing Philadelphia For more information, contact Anne Marie Coluccio, PTi international, at 212-661-3500 ext. 3229, e-mail [email protected], or visit pti-international.com. January 24-25 Manage the Cost of Spec...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
To Err is Human How Personal Health Records Can help It seems that a day doesn’t go by without hearing about health information technology (HIT). The healthcare system often is touted as one of our nation’s worst big-industry offenders when it comes to implementing HIT. This lack of HIT is to bla...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Raise your Voice Letters Medicare Drug Benefit – A Terrible Mistake The Medicare prescription drug bill voted on by Congress in November 2003 was a terrible mistake that will dearly cost our children and grandchildren. This was not a Medicare reform bill. This was barely a Medicare prescription d...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter From the Editor
Letter From The Editor More than 40% of executives recently surveyed by Datamonitor believe their companies are failing to commit adequate time and resources to portfolio management and futhermore, 25% believe their organizations have little ability to implement and execute portfolio management e...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover Prioritizing the pipeline: The role of portfolio management Increased pressures on the pharmaceutical industry ó from shrinking pipelines to rising costs, reimbursement issues, and regulatory pressures ó mean companies have to find ways to focus on the projects that will meet corpora...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your mind opinions Year in Review Continuing regulatory scrutiny, an economy yet to rebound, and evolving world events are some of the hallmarks for 2003. As 2004 approaches, PharmaVOICE asked how the trends and challenges of 2003 have impacted your business and how these market factors...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
January 2004 PharmaVOICE The forum for the industry executive portfolio management Strategies improving patient compliance with Dorothy Smith Device and Diagnostic Marketing www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies Market Measures/Cozint Forms Emerging Markets Team Group to focus exclusively on the market research needs of emerging pharma companies. Realizing that smaller and specialized companies involved in the healthcare field have unique requireme...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter From the Editor
Pharmaceutical manufacturers spent more in 2003 on new technology in most areas and less on maintaining existing technology than other manufacturing verticals, according to AMR Research. This is to be expected as many move to packaged or Web-based applications. Investments in databases, physical ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry New Drug Commercialization Costs Lead to Blockbuster Model’s End The high cost of commercialization is leading to the demise of the pharma industry’s blockbuster approach to developing new drugs, according to a stu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Ron Pantello THE HEALTHCARE COMMUNICATIONs INDUSTRY: ON THE BRINK OF FINANCIAL DISASTER? As many of us are witnessing, the healthcare communications industry is under siege. Economic constraints are so severe that the very existence of the industry as we know it is threatened. Yet ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Thomas Ebeling: A Leader on a Mission
A Leader on a Mission BY KIm Ribbink With a strong consumer background, Thomas Ebeling, CEO of Novartis Pharma AG and head of Novartis’ pharmaceuticals division worldwide, has the company positioned for growth. T homas Ebeling’s focus is to make sure Novartis is considered best in class by both d...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New electronic and web-based applications, sites, and technologies Oracle’s RDC to Speed Data Collection in Clinical Trials Oracle’s latest release of Clinical Remote Data Capture (RDC) features advances in usability, form design, and support for clinical trials. It provides the staff at ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-xpanding Sample Delivery
There’s an important reconciliation that must be made between the traditional methods of distributing drug samples and using e-sampling as a platform for greater marketplace penetration. How companies incorporate e-sampling into the business plan is the next challenge. Pharmaceutical product samp...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
February 2004 The forum for the industry executive Sharing knowledge Enterprisewide data management sales and marketing with Thomas Ebeling Small-Scale Research Nanotechnology www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a case for an Agency union A Union that Celebrates People Corbett and Accel have joined forces to form Corbett Accel Healthcare Group. The goal is to attract top talent and leverage each other’s strengths to provide the service integration required by forward-thinking clients on behalf of ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008
Previous
